Covid-19 Impact on Genotyping Assay Market, Global Research Reports 2020-2021

June 2020 | 98 pages | ID: C9B3B92BE4BDEN
QYResearch

Abstracts

This report covers market size and forecasts of Genotyping Assay, including the following market information:

• Global Genotyping Assay Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Genotyping Assay Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Genotyping Assay Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Genotyping Assay Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Illumina, Thermo Fisher Scientific, Roche Diagnostics Limited, Qiagen N.V., Danaher Corporation, Agilent Technologies, Fluidigm Corporation, GE Healthcare, Genewiz, Integrated Dna Technologies, Perkinelmer, Bio-Rad Laboratories, Eurofins Scientific, Pacific Biosciences of California, etc.

Based on the Region:

• Asia-Pacific (China, Japan, South Korea, India and ASEAN)
• North America (US and Canada)
• Europe (Germany, France, UK and Italy)
• Rest of World (Latin America, Middle East & Africa)

Based on the Type:

• PCR
• Sequencing
• Microarray
• Electrophoresis
• MALDI-TOF

Based on the Application:

• Pharmacogenomics
• Diagnostic Research
• Animal Genetics
• Agricultural Biotechnology

Contents

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Genotyping Assay Industry
1.7 COVID-19 Impact: Genotyping Assay Market Trends

2 GLOBAL GENOTYPING ASSAY QUARTERLY MARKET SIZE ANALYSIS

2.1 Genotyping Assay Business Impact Assessment - COVID-19
  2.1.1 Global Genotyping Assay Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Genotyping Assay Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 By Players, Global Genotyping Assay Quarterly Market Size, 2019 VS 2020
3.2 By Players, Genotyping Assay Headquarters and Area Served
3.3 Date of Key Players Enter into Genotyping Assay Market
3.4 Key Players Genotyping Assay Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON GENOTYPING ASSAY SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 PCR
  1.4.2 Sequencing
  1.4.3 Microarray
  1.4.4 Electrophoresis
  1.4.5 MALDI-TOF
4.2 By Type, Global Genotyping Assay Market Size, 2019-2021

5 IMPACT OF COVID-19 ON GENOTYPING ASSAY SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Pharmacogenomics
  5.5.2 Diagnostic Research
  5.5.3 Animal Genetics
  5.5.4 Agricultural Biotechnology
5.2 By Application, Global Genotyping Assay Market Size, 2019-2021
  5.2.1 By Application, Global Genotyping Assay Market Size by Application, 2019-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Illumina
  7.1.1 Illumina Business Overview
  7.1.2 Illumina Genotyping Assay Quarterly Revenue, 2020
  7.1.3 Illumina Genotyping Assay Product Introduction
  7.1.4 Illumina Response to COVID-19 and Related Developments
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Business Overview
  7.2.2 Thermo Fisher Scientific Genotyping Assay Quarterly Revenue, 2020
  7.2.3 Thermo Fisher Scientific Genotyping Assay Product Introduction
  7.2.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.3 Roche Diagnostics Limited
  7.3.1 Roche Diagnostics Limited Business Overview
  7.3.2 Roche Diagnostics Limited Genotyping Assay Quarterly Revenue, 2020
  7.3.3 Roche Diagnostics Limited Genotyping Assay Product Introduction
  7.3.4 Roche Diagnostics Limited Response to COVID-19 and Related Developments
7.4 Qiagen N.V.
  7.4.1 Qiagen N.V. Business Overview
  7.4.2 Qiagen N.V. Genotyping Assay Quarterly Revenue, 2020
  7.4.3 Qiagen N.V. Genotyping Assay Product Introduction
  7.4.4 Qiagen N.V. Response to COVID-19 and Related Developments
7.5 Danaher Corporation
  7.5.1 Danaher Corporation Business Overview
  7.5.2 Danaher Corporation Genotyping Assay Quarterly Revenue, 2020
  7.5.3 Danaher Corporation Genotyping Assay Product Introduction
  7.5.4 Danaher Corporation Response to COVID-19 and Related Developments
7.6 Agilent Technologies
  7.6.1 Agilent Technologies Business Overview
  7.6.2 Agilent Technologies Genotyping Assay Quarterly Revenue, 2020
  7.6.3 Agilent Technologies Genotyping Assay Product Introduction
  7.6.4 Agilent Technologies Response to COVID-19 and Related Developments
7.7 Fluidigm Corporation
  7.7.1 Fluidigm Corporation Business Overview
  7.7.2 Fluidigm Corporation Genotyping Assay Quarterly Revenue, 2020
  7.7.3 Fluidigm Corporation Genotyping Assay Product Introduction
  7.7.4 Fluidigm Corporation Response to COVID-19 and Related Developments
7.8 GE Healthcare
  7.8.1 GE Healthcare Business Overview
  7.8.2 GE Healthcare Genotyping Assay Quarterly Revenue, 2020
  7.8.3 GE Healthcare Genotyping Assay Product Introduction
  7.8.4 GE Healthcare Response to COVID-19 and Related Developments
7.9 Genewiz
  7.9.1 Genewiz Business Overview
  7.9.2 Genewiz Genotyping Assay Quarterly Revenue, 2020
  7.9.3 Genewiz Genotyping Assay Product Introduction
  7.9.4 Genewiz Response to COVID-19 and Related Developments
7.10 Integrated Dna Technologies
  7.10.1 Integrated Dna Technologies Business Overview
  7.10.2 Integrated Dna Technologies Genotyping Assay Quarterly Revenue, 2020
  7.10.3 Integrated Dna Technologies Genotyping Assay Product Introduction
  7.10.4 Integrated Dna Technologies Response to COVID-19 and Related Developments
7.11 Perkinelmer
  7.11.1 Perkinelmer Business Overview
  7.11.2 Perkinelmer Genotyping Assay Quarterly Revenue, 2020
  7.11.3 Perkinelmer Genotyping Assay Product Introduction
  7.11.4 Perkinelmer Response to COVID-19 and Related Developments
7.12 Bio-Rad Laboratories
  7.12.1 Bio-Rad Laboratories Business Overview
  7.12.2 Bio-Rad Laboratories Genotyping Assay Quarterly Revenue, 2020
  7.12.3 Bio-Rad Laboratories Genotyping Assay Product Introduction
  7.12.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.13 Eurofins Scientific
  7.13.1 Eurofins Scientific Business Overview
  7.13.2 Eurofins Scientific Genotyping Assay Quarterly Revenue, 2020
  7.13.3 Eurofins Scientific Genotyping Assay Product Introduction
  7.13.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.14 Pacific Biosciences of California
  7.14.1 Pacific Biosciences of California Business Overview
  7.14.2 Pacific Biosciences of California Genotyping Assay Quarterly Revenue, 2020
  7.14.3 Pacific Biosciences of California Genotyping Assay Product Introduction
  7.14.4 Pacific Biosciences of California Response to COVID-19 and Related Developments

8 KEY FINDINGS

9 APPENDIX

9.1 About US
9.2 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Genotyping Assay Assessment
Table 9. COVID-19 Impact: Genotyping Assay Market Trends
Table 10. COVID-19 Impact Global Genotyping Assay Market Size
Table 11. Global Genotyping Assay Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Genotyping Assay Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Genotyping Assay Market Growth Drivers
Table 14. Global Genotyping Assay Market Restraints
Table 15. Global Genotyping Assay Market Opportunities
Table 16. Global Genotyping Assay Market Challenges
Table 17. By Players, Genotyping Assay Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Genotyping Assay Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Genotyping Assay Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Genotyping Assay Market
Table 21. Key Players Genotyping Assay Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Genotyping Assay Market Size 2019-2021, (US$ Million)
Table 24. Global Genotyping Assay Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Genotyping Assay Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Genotyping Assay Market Size, 2019-2021 (US$ Million)
Table 57. Illumina Business Overview
Table 58. Illumina Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Illumina Genotyping Assay Product
Table 60. Illumina Response to COVID-19 and Related Developments
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Thermo Fisher Scientific Genotyping Assay Product
Table 64. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 65. Roche Diagnostics Limited Business Overview
Table 66. Roche Diagnostics Limited Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Roche Diagnostics Limited Genotyping Assay Product
Table 68. Roche Diagnostics Limited Response to COVID-19 and Related Developments
Table 69. Qiagen N.V. Business Overview
Table 70. Qiagen N.V. Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Qiagen N.V. Genotyping Assay Product
Table 72. Qiagen N.V. Response to COVID-19 and Related Developments
Table 73. Danaher Corporation Business Overview
Table 74. Danaher Corporation Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Danaher Corporation Genotyping Assay Product
Table 76. Danaher Corporation Response to COVID-19 and Related Developments
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Agilent Technologies Genotyping Assay Product
Table 80. Agilent Technologies Response to COVID-19 and Related Developments
Table 81. Fluidigm Corporation Business Overview
Table 82. Fluidigm Corporation Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Fluidigm Corporation Genotyping Assay Product
Table 84. Fluidigm Corporation Response to COVID-19 and Related Developments
Table 85. GE Healthcare Business Overview
Table 86. GE Healthcare Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. GE Healthcare Genotyping Assay Product
Table 88. GE Healthcare Response to COVID-19 and Related Developments
Table 89. Genewiz Business Overview
Table 90. Genewiz Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Genewiz Genotyping Assay Product
Table 92. Genewiz Response to COVID-19 and Related Developments
Table 93. Integrated Dna Technologies Business Overview
Table 94. Integrated Dna Technologies Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Integrated Dna Technologies Genotyping Assay Product
Table 96. Integrated Dna Technologies Response to COVID-19 and Related Developments
Table 97. Perkinelmer Business Overview
Table 98. Perkinelmer Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Perkinelmer Genotyping Assay Product
Table 100. Perkinelmer Response to COVID-19 and Related Developments
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Bio-Rad Laboratories Genotyping Assay Product
Table 104. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 105. Eurofins Scientific Business Overview
Table 106. Eurofins Scientific Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Eurofins Scientific Genotyping Assay Product
Table 108. Eurofins Scientific Response to COVID-19 and Related Developments
Table 109. Pacific Biosciences of California Business Overview
Table 110. Pacific Biosciences of California Genotyping Assay Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Pacific Biosciences of California Genotyping Assay Product
Table 112. Pacific Biosciences of California Response to COVID-19 and Related Developments

List Of Figures

LIST OF FIGURES

Figure 1. Genotyping Assay Product Picture
Figure 2. Genotyping Assay Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Genotyping Assay Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Genotyping Assay Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Genotyping Assay Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Genotyping Assay Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Genotyping Assay Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Genotyping Assay Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Genotyping Assay Market Size Market Share, 2019-2021